| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/05/2023 | 201.72% | RBC Capital | → $7 | Initiates Coverage On | → Outperform |
| 07/31/2023 | 546.55% | EF Hutton | → $15 | Initiates Coverage On | → Buy |
| 03/23/2023 | 503.45% | Credit Suisse | → $14 | Reiterates | → Outperform |
| 11/02/2021 | 589.66% | B of A Securities | → $16 | Initiates Coverage On | → Neutral |
| 11/02/2021 | 977.59% | Jefferies | → $25 | Initiates Coverage On | → Buy |
| 11/02/2021 | 718.97% | Credit Suisse | → $19 | Initiates Coverage On | → Outperform |
What is the target price for Pyxis Oncology (PYXS)?
The latest price target for Pyxis Oncology (NASDAQ: PYXS) was reported by RBC Capital on September 5, 2023. The analyst firm set a price target for $7.00 expecting PYXS to rise to within 12 months (a possible 201.72% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pyxis Oncology (PYXS)?
The latest analyst rating for Pyxis Oncology (NASDAQ: PYXS) was provided by RBC Capital, and Pyxis Oncology initiated their outperform rating.
When is the next analyst rating going to be posted or updated for Pyxis Oncology (PYXS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pyxis Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pyxis Oncology was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.
Is the Analyst Rating Pyxis Oncology (PYXS) correct?
While ratings are subjective and will change, the latest Pyxis Oncology (PYXS) rating was a initiated with a price target of $0.00 to $7.00. The current price Pyxis Oncology (PYXS) is trading at is $2.32, which is within the analyst's predicted range.